ArdC, a ssDNA-binding protein with a metalloprotease domain, overpasses the recipient hsdRMS restriction system broadening conjugation host range
Authors:
Lorena González-Montes aff001; Irene del Campo aff001; M. Pilar Garcillán-Barcia aff001; Fernando de la Cruz aff001; Gabriel Moncalián aff001
Authors place of work:
Departamento de Biología Molecular, Universidad de Cantabria and Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), CSIC-Universidad de Cantabria, Santander, Cantabria, Spain
aff001
Published in the journal:
ArdC, a ssDNA-binding protein with a metalloprotease domain, overpasses the recipient hsdRMS restriction system broadening conjugation host range. PLoS Genet 16(4): e32767. doi:10.1371/journal.pgen.1008750
Category:
Research Article
doi:
https://doi.org/10.1371/journal.pgen.1008750
Summary
Plasmids, when transferred by conjugation in natural environments, must overpass restriction-modification systems of the recipient cell. We demonstrate that protein ArdC, encoded by broad host range plasmid R388, was required for conjugation from Escherichia coli to Pseudomonas putida. Expression of ardC was required in the recipient cells, but not in the donor cells. Besides, ardC was not required for conjugation if the hsdRMS system was deleted in P. putida recipient cells. ardC was also required if the hsdRMS system was present in E. coli recipient cells. Thus, ArdC has antirestriction activity against the HsdRMS system and consequently broadens R388 plasmid host range. The crystal structure of ArdC was solved both in the absence and presence of Mn2+. ArdC is composed of a non-specific ssDNA binding N-terminal domain and a C-terminal metalloprotease domain, although the metalloprotease activity was not needed for the antirestriction function. We also observed by RNA-seq that ArdC-dependent conjugation triggered an SOS response in the P. putida recipient cells. Our findings give new insights, and open new questions, into the antirestriction strategies developed by plasmids to counteract bacterial restriction strategies and settle into new hosts.
Keywords:
DNA-binding proteins – Crystal structure – Plasmid construction – Plasmids – Pseudomonas putida – Horizontal gene transfer – Electrophoretic mobility shift assay – Metalloproteases
Introduction
Horizontal gene transfer (HGT) is the transmission of genetic material between organisms that are not in a parent–progeny relationship [1]. The clinical relevance of the HGT process lies in the acquisition and dissemination of genes involved in conferring bacterial resistance to antibiotics (AbR) between unrelated pathogens. When bacteria face selective pressures, as those exerted by antibiotics, horizontal acquisition of AbR allows the diversification of the genomes, increasing survival opportunities [2]. Conjugation is the main HGT process that allows the transfer of genes encoded in autonomous plasmids. This process requires the machinery to build a direct contact between a donor and a recipient cell [1]. Conjugation can be modulated by environmental factors or bacterial strategies based on genetic approaches that are coded in the chromosome (host barriers) or plasmid DNA (plasmid barriers). Plasmid barriers include entry exclusion [3] or fertility inhibition [4], which reduce conjugative transfer. Host barriers can be mediated through SOS response modulation [5,6], CRISPR-Cas systems [7] or restriction and modification (R-M) systems.
R-M systems allow bacteria to discern between self and foreign DNA invading the cell, leading to its destruction. They require two enzymatic activities: a methyltransferase that provides protection to its own DNA and an endonuclease that cleaves the unmethylated invading DNA [8]. There are four main groups of R-M systems. Type I R-M, the most sophisticated R-M system, requires three genes: hsdR, hsdM, and hsdS and their products associate in R2M2S complexes. The S subunit recognizes 13–15 bp sequences, usually asymmetric and bipartite. DNA cleavage is at a location away from the specificity site [9–11]. There is a coevolutionary arms race between bacteria to avoid entrance of foreign DNA molecules and parasitic DNA molecules such as plasmids or bacteriophages to enter a putative host avoiding the restriction by bacterial R-M systems. The antirestriction mechanisms to counteract R-M systems can be divided into four main types based on its mode of action: DNA modification, transient occlusion of restriction sites, sabotage of host R-M activities, and inhibition of restriction enzymes [10].
R388 plasmid is the prototype of the IncW incompatibility group of plasmids. IncW plasmids have a low copy number, a wide range of AbR, and a broad host range (BHR) [12]. R388 has 35 genes assorted in functional groups or modules, among them, a gene coding for an antirestriction protein called ArdC [12]. Here, we present ArdC crystal structures and the ardC role in interspecies conjugation. We have also identified transcriptional changes associated with ardC-mediated conjugation. These results show that ArdC is involved in broadening the R388 plasmid host range.
Results
ardC is required for R388 conjugation from E. coli to P. putida
R388 plasmid (GenBank Accession Number BR000038.1) is composed of three functional sectors (S1 Fig): one for general maintenance (modules of replication, stable inheritance and establishment) located in the leading region, a sector for AbR and integration, and a third one for conjugation (modules of DNA transfer replication and mating pore formation) [12]. We expected the stable inheritance and establishment region to be required in interspecies conjugation. pSU2007, a KnR R388 derivative, was transferred with different efficiencies from E. coli BW27783-NxR to other bacteria (Fig 1A). The transfer of pIC10 (R388ΔkfrA-orf14), an R388 derivative without the stability and maintenance region, was more dissimilar to that of pSU2007 from E. coli to P. putida KT2440 where the conjugation frequency dropped around 1000-fold. In the stability and maintenance gene region deleted in pIC10 there are 13 genes that code for proteins homologous to some with predicted function of fertility inhibition (osa) [13], proteins of unknown function (klcB, nuc1, nuc2, orf7, orf8, orf9, orf12, and orf14), transcriptional regulators (kfrA, and ardK), ssDNA binding protein (ssb), and antirestriction (ardC). ArdC protein (297 amino acids and 33.2 KDa, GenBank Acc. No. FAA00054.1) exhibited an in vitro antirestriction function towards Type I and II R-M systems [14]. Thus, we constructed plasmid pLGM25 (R388ΔardC) to check if the effect observed in conjugation with pIC10 could be due to the lack of the ardC gene. This plasmid was introduced into E. coli BW27783-NxR and then conjugated to E. coli BW27783-RifR or P. putida KT2440 (Fig 1B). We observed that the absence of ardC in the conjugative plasmid pLGM25 reduced the conjugation frequency to P. putida from 3.8E-02 to 9.0E-05, but not to E. coli. Thus, the results observed for pIC10 could be explained to a large extent by ardC absence.
ardC is needed in recipient cells
To check if ArdC was needed in donor or recipient cells, transfer of ΔardC pLGM25 plasmid was measured when complemented by the overexpression of ardC in donor E. coli cells, or in recipient P. putida cells. As shown in Fig 1C, ardC did not improve the conjugation frequency when overexpressed in donors. On the other hand, overexpression of ardC in recipient cells increased the conjugation frequencies, reaching pSU2007 conjugation levels. Thus, it seems that the expression of ArdC is specifically required in the recipient, and not in donor cells.
ArdC is a ssDNA-binding protein with a metalloprotease domain
R388 ArdC crystal structure was solved at 2.6 Å resolution using a selenomethionine-derivative protein structure solved by single anomalous dispersion as described in Materials and Methods. Using this preliminary structure, the apo ArdC structure was solved at 2.0 Å resolution by molecular replacement (MR). Apo ArdC crystallized in the H3 space group containing one molecule per asymmetric unit. Data collection and refinement statistics are given in Table 1.
ArdC is composed of two structural domains: An N-terminal domain (residues 1–134) and a C-terminal domain (residues 151–297) joined by a long and flexible loop (135–150) (Fig 2A and 2B). Electron density was not observed for the N-terminal residues 1–6, the flexible small loop residues 33–39, residues 136–141 in the region connecting both domains and C-terminal residues 294–297. The N-terminal domain is composed of three α-helices (α1-α3), a three-stranded β-sheet (β1, β3, and β4) that supports a long and protuberant β-hairpin (β3-β4), a smaller two-stranded antiparallel β-sheet formed by β2 and β5, as well as three 310 helices labeled from η1 to η3 (Fig 2A and 2B). The C-terminal domain is composed of six α-helices (α4-α9) and short three-stranded antiparallel β-sheets (β6-β8) as shown in Fig 2A and 2B.
The ArdC structure was compared to those deposited in the PDB using the Dali server [16]. ArdC N-terminal domain closest structural homolog is present in a nucleotide excision repair protein called Rad4 (PDB: 2QSG; Z-score: 4.5), a component of the eukaryotic nucleotide excision repair (NER) pathway. Rad4 is composed of an inactive transglutaminase fold domain and three different β-hairpin domains (BHD). The three tandem BHD domains form a large DNA binding surface [17]. ArdC N-terminal domain is more similar at a sequence level to the second BHD domain of Rad4 (BHD2), although BHD2 is considerable smaller (about 50 amino acids long compared to the 134 residues of ArdC-N). It lacks some ArdC-N structural features, such as the starter ArdC α1, α2, and final 310 motifs. Moreover, the protuberant β-hairpin formed by β3 and β4 is larger in ArdC (Fig 3A). ArdC N-terminal domain possesses the V121FNADQ126 sequence located within a 310 helix (η2) between β4 and β5 (Fig 2B). This region forms a crossover with the β2 to β3 region and creates a sharp twist of the chain known as the “squiggle” motif [15]. This motif in Rad4 is proposed to be responsible for a highly flexible region that could facilitate recognition of DNA sequences.
The surface electrostatic map (Fig 2D) reveals a positively charged groove in the region of the N-terminal domain adjacent to the C-terminal domain, suggesting a DNA binding site between both structural domains. By electrophoretic mobility shift assays (EMSA), we determined that ArdC preferentially binds ssDNA oligonucleotides over dsDNA molecules (Fig 4) in accordance with previous results [14]. Moreover, binding to partial dsDNA with 5’ or 3’ terminal ssDNA overhangs is preferred over binding to perfectly paired complementary dsDNA duplex (Fig 4). We will name ArdC N-terminal domain hereafter ssDNA-binding domain (ssDBD).
Regarding the C-terminal domain (amino acids 151–297), according to the Dali server [16] the closest structural homologs were the DNA binding metalloproteases Spartan (PDB: 6MDW; Z-score: 6.4) and IrrE (PDB: 3DTE; Z-score: 5.5) (Fig 3C and 3D). Spartan is a protein involved in the cleavage of proteins irreversibly cross-linked to DNA to preserve this way genome stability [18]. IrrE protects D. radiodurans from UV radiation DNA damage by proteolysis of a negative transcriptional regulator, DdrO, which represses the expression of DNA damage response genes involved in SOS response [19]. These proteins belong to the gluzinzin metalloprotease family characterized by the presence of the conserved residues HExxH located on the “active site helix” (α5 in ArdC) and an additional conserved motif (E,H)xx(A,F,T,S,G) located in the contiguous α-helix or “glutamate helix” (α7 in ArdC) [20] (Fig 2A and 2B). The surface electrostatic map revealed a negatively charged catalytic pocket (Fig 2D). We will name ArdC C-terminal metalloprotease domain MPD.
The two histidines of the active site helix and the glutamic acid of the glutamate helix have been shown to coordinate a catalytic divalent metal ion, usually zinc. However, gluzinzin metalloproteases maintain the catalytic activity with Co2+, Mn2+ or Ni2+ too due to the flexibility of these three metal coordination geometries [20,21]. To assess the metal used by ArdC the stability of ArdC was assayed in the presence of different metal cofactors. ArdC showed increased thermal stability (assayed by ThermoFluor) in the presence of Ni2+, Mn2+ or Co2+ (ΔTM> 4°C), but not in the presence of Zn2+, Ca2+, Mg2+, Cu2+ or Fe3+ (S1 Table). Moreover, to know the conformation of the active site when bound to metals, ArdC was crystallized in the presence of MnCl2 (Materials and Methods). ArdC-Mn crystallized in the P32 space group containing eight molecules per asymmetric unit and the structure was solved at 2.7 Å (Table 1). Mn2+ is tetrahedrally coordinated by H201, H205, E229 and an H2O molecule (Fig 2C). H205 is oriented towards the metal by interaction with the conserved E228 through the non-coordinating nitrogen atom. The E202 residue of the HE202xxH motif orients and acts as a catalytic base for the activation of a water molecule that coordinates the metal. The H2O molecule could act as a Lewis acid to allow the nucleophilic attack [20]. By analogy with other gluzinzin metalloproteases, the conserved ArdC residue Y255 could stabilize by a hydrogen bond the polypeptide chain to be cleaved [22]. The metalloprotease sub-domain (MPsD) in Spartan shares the active center structure with ArdC MPD except that MPsD uses a third histidine instead of a glutamic acid for metal coordination (Fig 3B).
It had been proposed that ArdC could avoid ssDNA degradation by HhaI, a type II restriction enzyme able to cleave both ssDNA and dsDNA [14]. According to our structural results, this ArdC DNA protection could be due to ArdC MPD activity targeting the restriction enzyme. To test this hypothesis, the inhibition of HhaI by ArdC was assayed in the presence of ssDNA M13mp18 (7.2 kb) and Mg2+. As observed in S2 Fig, ArdC was able to avoid ssDNA cleavage by HhaI but we did not observe HhaI degradation by ArdC.
Since its 3D structure defined ArdC as a protease, we tried to find a specific protein target. ArdC mutant E229A (supposed to be inactive) was purified and used as prey for co-purification of potential targets in P. putida KT2440 cell lysate by the pull-down technique. The only protein that co-eluted with ArdC was PP_0941, a protein of unknown function similar to the 50S ribosome subunit associated protein YjgA (S3 Fig).
SOS response is activated in P. putida recipient cells by the transfer of an ardC-containing plasmid
IrrE, the bacterial closest structural homolog to ArdC, triggers SOS response by cleaving the transcriptional regulator DdrO in an analogous way to the RecA-LexA system [19]. To check if ArdC could have similar activity on plasmid conjugation, we analyzed by RNA-seq changes in gene expression when an ardC-containing plasmid was transferred from E. coli to P. putida. As described in Materials and Methods, P. putida KT2440 was mixed in a conjugation filter with either E. coli BW27783-NxR bearing no plasmid (NP), E. coli BW27783-NxR bearing pSU2007 (ardC+) or E. coli BW27783-NxR bearing pLGM25 (ardC-).
As expected according to the results shown in Fig 1B, significant conjugation frequency differences between ardC+ and ardC−conditions were observed (S2 Table). RNA-seq results (S3–S5 Tables and S4 Fig) showed that: (a) R388 genes involved in conjugation are highly upregulated in the ardC+ condition regarding the ardC−condition (S5 and S6 Tables and S4A Fig). This is consistent with the zygotic induction observed in the recipient cells after conjugation [23]; (b) several donor E. coli genes and pathways involved in flagellar motility, SOS and stress responses and different metabolic pathways are downregulated in the ardC−condition regarding the NP or ardC+ conditions (S5 and S7 Tables, and S4B Fig); (c) SOS genes are upregulated in recipient P. putida cells when receiving ardC+ containing plasmid with respect to NP or ardC−conditions. Differential expression of P. putida genes in recipient cells when the ardC-containing plasmid is transferred is shown in S8 Table and S4C Fig.
ArdC metalloprotease activity is not required for conjugation to P. putida
Being ArdC a ssDNA binding protein with a metalloprotease domain, we checked if this proteolytic activity was needed for ArdC activity in conjugation. The ardC gene was mutated to ardC_E229A in pSU2007 to generate plasmid pLGM33. Mutation of the glutamic acid of the active site involved in metal coordination to alanine, E229A, is expected to deactivate the proteolytic center of ArdC, as it occurs in other family members. Plasmids pSU2007 or pLGM33 were conjugated from E. coli to P. putida. Surprisingly, pLGM33 conjugation frequency resulted to be like that of pSU2007, around 0.01 transconjugants per recipient (T/R) (Fig 5A). Besides, the ardC_E229A mutant gene was tested for its ability to complement pLGM25 (R388 ΔardC) plasmid in mating experiments from E. coli to P. putida KT2440. The in trans expression of ardC_E229A in P. putida KT2440 recipient cells was able to increase the conjugation frequency of pLGM25 at the same levels as the expression of the wt ardC gene (Fig 5B). Thus, ArdC metalloprotease activity is not required for the host range broadening activity at least in P. putida.
ArdC counteracts the HsdRMS system in both P. putida and E. coli
To identify the functional target of ArdC, different P. putida mutant strains were assessed as recipients in mating experiments. RecA dependent SOS response is activated in ardC+ conjugation recipient cells as shown by the RNA-seq experiments (S8 Table). To check the role of this response in conjugation, firstly pSU2007 and pLGM25 were conjugated from E. coli to P. putida KT2440ΔrecA. The frequency of conjugation of pSU2007 to P. putida KT2440ΔrecA was about 10−2 T/R (Fig 6A). Thus, RecA dependent SOS response in P. putida recipient cells is not essential for conjugation. Moreover, the frequency of conjugation of pLGM25 to P. putida KT2440ΔrecA was around 10−4 T/R, meaning that the absence of recA does not enhance conjugation in the absence of ardC. In addition, pSU2007 and pLGM25 were conjugated from E. coli to P. putida EM42, which carries deletions of several prophages and other accessory genes (Δprophage1 Δprophage4 Δprophage3 Δprophage2 Δtn7 ΔendA-1 ΔendA-2 ΔhsdRMS Δflagellum Δtn4652) that could harass the heterologous gene expression (because their association to genetic instability or attributed to the unfruitful usage of metabolic resources). Any of these genes removed from P. putida EM42 could affect the establishment of the plasmids acquired by conjugation. The conjugation frequency towards EM42 strain was not affected by the ardC deletion (Fig 6A) indicating that ArdC could be counteracting the action of the products of one or more of the deleted genes in the EM42 strain. To identify the gene(s) responsible for the observed phenotype, pSU2007 and pLGM25 were conjugated from E. coli to P. putida mutants with deletions in single or several genes. pLGM25 only reached pSU2007 conjugation levels (around 0.1 T/R) in the P. putida KT2449ΔhsdRMS strain EM422 (Fig 6A). Similar results were observed at 30°C (S5 Fig). The hsdRMS operon was thus the main responsible for the effect observed in EM42. pLGM25 was efficiently transferred between P. putida KT2440, being its conjugation frequency around 0.1 T/R (Fig 6B). However, pLGM25 transfer drastically dropped from P. putida EM422 (ΔhsdRMS) to P. putida KT2440 unless pLGM36 was present in the P. putida KT2440 recipient cell. Thus, ardC is counteracting the effect of the HsdRMS R-M system in the incoming DNA.
The E. coli strain BW27783 used as donor and recipient in the mating experiments shown in Fig 1B was a non-restricting and modifying strain (rK-mK+), and thus not suitable to check for the ArdC effect in R388 conjugation between E. coli cells. So, to evaluate if the E. coli HsdRMS R-M system was also targeted by ArdC, a non-restricting and non-modifying (rB-mB-) E. coli strain, BL21(DE3), was used as a donor. When pLGM25 was transferred to E. coli MG1655 (rK+mK+) its conjugation frequency significantly decreased in comparison to pSU2007 transfer, but not to E. coli BW27783 (rK-mK+) (Fig 6C). Moreover, the conjugation frequency was again rescued when ArdC was expressed in the recipient cell.
Discussion
Antibiotic resistance determinants and xenobiotic degradation genes are extensively disseminated in different ecological niches by conjugative BHR plasmids. BHR plasmids evolved different strategies to avoid obstacles to their entrance in new recipient cells. In this article, we determined that ArdC protein, produced by the IncW BHR plasmid R388, is required for interspecies conjugation from E. coli to P. putida. ArdC was first studied by [14], who showed an in vitro antirestriction function towards Type I and II R-M systems. They observed that ArdC showed a 38% identity with the N-terminal region (about 300 amino acids, DUF1738 domain (pfam08401)) of TraC1 primase from RP4 plasmid. Since TraC1 travels to the recipient cell during conjugation presumably bound to the ssDNA that is being transferred (T-strand) [14], they proposed that ArdC could be also transferred during conjugation bound to the plasmid T-strand. Besides, they proposed that ArdC protects the incoming DNA from host endonucleases through restriction site occlusion. However, they failed to detect any significant influence of ArdC on the efficiency of an IncW plasmid transfer between a non-restricting and non-modifying donor E. coli and an EcoK-restricting recipient E. coli strain. We demonstrated in this work that ArdC plays indeed an in vivo function in IncW plasmid conjugation. ArdC role involves its expression in recipient cells. Consequently, complementation of pLGM25 (R388ΔardC) with ardC in donor cells neither recovered wt plasmid conjugation frequencies from E. coli to P. putida nor between E. coli strains, while ArdC expression in the recipient cells did. Thus, although our experiments do not rule out ArdC export during conjugation in the wild type system, it is not a requirement for its activity, contrary to what was proposed [14]. TraC1 of RP4 and Sog primases of IncI1 plasmids are transferred to the recipient cell during conjugation[24]. They have in common a topoisomerase-primase (TOPRIM) domain located either in the C-terminal part of TraC1 or the N-terminal part of Sog. Both primases differ in that TraC1 contains the DUF1738 domain, which is also present in ArdC. TOPRIM is not present in ArdC. The antirestriction activity of the TraC1 primase has not been investigated but, in the light of our results is a reasonable hypothesis. In any case, a putative TraC1 antirestriction activity seems redundant, since antirestriction against the Type I R-M system was demonstrated both in vivo [25] and in vitro [26] for KlcA, another RP4 protein.
DUF1738 and TOPRIM domain accretion in a single protein seems to be a specific adaptation. Inspection of the RefSeq plasmid database (version 90) using Hidden Markov Model searches for TOPRIM (PF13362) and DUF1738 (PF08401) domains revealed the presence of 1,334 TOPRIM-containing proteins and 877 DUF1738-containing proteins. Only 84 plasmid proteins contained both domains and they were encoded in 83 plasmids. Additionally, 203 plasmids encoded both domains, but each in a separate protein thus totalling 286 plasmids encoding both DUF1738 and TOPRIM domains, either fused or independent (S6 Fig). An overwhelming proportion of plasmids encoding either DUF1738 or TOPRIM domains also encoded a MOB relaxase and can thus be considered transmissible by conjugation [27]: 939 out of 1242 TOPRIM-encoding plasmids, 667 out of 831 DUF1738-encoding plasmids, 252 out of 286 DUF1738+TOPRIM-encoding plasmids, and 82 out of 83 plasmids encoding both domains in the same protein. While transmissible plasmids encoding TOPRIM and DUF1738 domains in separate proteins were distributed in seven different MOB classes, all but one of those encoding both domains in the same polypeptide belonged to the MOBP class (roughly half of them IncP1 plasmids).
Further information about ArdC activity was obtained by solving its crystal structure. Interestingly, ArdC contains an N-terminal ssDNA binding domain and a C-terminal metalloprotease domain. ArdC is structurally similar to DNA-binding dependent metalloproteases involved in the maintenance of genetic stability such as Spartan or IrrE. Human Spartan protein cleaves DNA-protein crosslinks [18], while IrrE plays a central regulatory role in DNA protection and repair pathways in response to radiation [19]. ArdC structure differs from other known plasmid-encoded antirestriction proteins. ArdA from the conjugative transposon Tn916 (2W82) is structurally similar to the B-form DNA, this way binding Type I R-M systems to avoid DNA degradation [28]. KlcA (PDB:2KMG) from the IncP-1β plasmid pBP136 and ArdB (PDB:2WJ9) are composed of a single α/β domain inhibiting the endonuclease activity of Type I R-M systems by an indirect mechanism not related to the mimic of DNA structure [29]. According to our solved structure, we expect ArdC to provide a new antirestriction mechanism.
We observed SOS response activation in P. putida recipient cells during ardC+-mediated conjugation from E. coli. ArdC could trigger SOS response in recipient cells similarly than IrrE triggers SOS response upon radiation damage (by proteolysis of DdrO, a transcriptional regulator involved in SOS response) [30]. However, it has also been described that conjugative ssDNA activates SOS response when the plasmid cannot replicate in the recipient [31]. As ArdC_E229A mutant is still able to promote R388 conjugation to P. putida, we think that activation of the SOS response in the recipient is the consequence of the ongoing conjugative process and not a direct effect of the presumed proteolytic activity of ArdC. We hypothesize that the high affinity of ArdC by ssDNA could delay the complementary strand replication resulting in a transient higher amount of ssDNA and thus triggering the SOS response. This is supported by the fact that pLGM25 transfer to P. putida did not result in SOS activation.
Since ArdC is not required for R388 conjugation either to P. putida KT2440ΔhsdRMS or to E. coli ΔhsdR, it is expected to play a role as counteracting Type I R-M system, probably preventing degradation of the transferred DNA. Moreover, ArdC is not required for R388 conjugation between P. putida KT2440 strains. Consequently, once R388 is modified by the HsdRMS system, it can be properly transferred to another cell also containing the same HsdRMS system. Type I R-M systems attack dsDNA and thus are not expected to degrade ssDNA during bacterial conjugation. However, it has been reported that the EcoKI R-M system affects the uptake of DNA by conjugation [32] and, ArdC is not expressed until plasmid DNA is in dsDNA shape. Thus, Type I R-M system could be attacking late, once ArdC is generated from the dsDNA plasmid after DNA entrance and establishment in recipient cells. In this respect, the observation that mutation of the ArdC metalloprotease active center does not reduce interspecies conjugation suggests that the metalloprotease activity is not required during conjugative transfer to P. putida. The presumed metalloprotease activity is not expected to play a role in HsdRMS activity. Thus, it is tempting to propose that, just by ArdC binding to DNA, the protein interferes with HsdRMS binding and thereby hindering the degradation of its target DNA.
In summary, our results indicate a new mechanism of DNA antirestriction played by protein ArdC, by which plasmids increase their conjugation host range. Interfering with ArdC activity could thus provide a new tool to hinder the transmission of antibiotic resistance.
Materials and methods
Conjugation assays
Conjugation assays were performed by mixing E. coli or P. putida cells (Table 2) containing the plasmid of interest (Table 3) with recipient cells grown overnight at their optimal growing temperature. E. coli cells were grown at 37 ºC and P. putida at 30 ºC. Cells at OD600 = 0.6 were mixed in a 1: 1 donor: recipient ratio, washed on LB medium, resuspended in 30 μL of LB and deposited on a 0.22 μm pore size cellulose acetate filters (Sartorius Stedim) in LB-agar plates previously incubated at 37ºC unless otherwise indicated. After 1 h, filters were removed with sterile tweezers and introduced in 1 mL LB, where cells were resuspended by vortexing for a few seconds. 1/10 serial dilutions were done and 10 μL drops were plated in LB agar plates with the appropriate selecting antibiotics for donors, recipients and transconjugants. Conjugation frequencies were obtained by dividing transconjugants per recipients (T/R). For conjugations in the presence of pUCP22-derived plasmids, isopropyl β-D-thiogalactoside (IPTG) was added to the conjugation mixture to a 0.1 mM IPTG final concentration. Means and standard deviations, as well as statistical tests, were calculated with GraphPad Prism1 (v 7.04) biostatistics software.
Transcriptomic analysis
Mixtures of E. coli BW27783-NxR (bearing pSU2007, pLGM25 or no plasmid) with P. putida KT2440 were carried out by the already described conjugation assay in a 5:1 donor: recipient ratio for 30 minutes. Harvested cells from the conjugation filter were treated with RNAprotect® Bacteria Reagent (Qiagen) and snap-frozen. Cells were lysed with lysozyme (Sigma) and proteinase K (Roche). Total RNA was extracted with RNeasy Mini Kit (Qiagen) and treated with RNase-free DNase (Qiagen) in column for DNA removal. Ambion TURBO DNA-free™ DNase Treatment was also applied for better DNA removal. RNA integrity and quality were validated by the Agilent RNA ScreenTape assay. The RNA integrity number equivalent (RINe) was assured to be above 8 to use the isolated RNA in the RNA-seq experiment.
Transcriptome libraries were prepared by Macrogen (Seoul, Korea) with Ribo-Zero rRNA Removal Kit and TruSeq Stranded mRNA sample preparation kit (Illumina). Libraries were sequenced by Macrogen on the Illumina HiSeq 4000 platform. The transcriptome libraries were paired-end sequenced with 100-bp reads. Raw reads in FASTQ format were quality analyzed with FastQC [52]. Reads were mapped against R388 (NCBI Accession number NC_028464.1), E. coli str. K-12 substr. MG1655 (U00096.3) and P. putida KT2440 (AE015451.2) sequences. The alignment of reads was done with Bowtie2 software [53]. Artemis program [54] was used to visualize the alignment and do the RPKM (reads per kilobase and million mapped reads) calculations. Genes with less than 10 RPKMs in all experimental conditions were removed from the analysis. DAVID online tool v6.8 [55] was used to test for gene ontology enrichment among the list of differentially expressed genes to do a functional classification.
Protein expression and purification
Plasmids pLGM21 (pET29c::ardC) or pLGM28 (pET29c::ardC_E229A) were transformed into electrocompetent Escherichia coli BL21 (DE3) cells (Table 2). Transformed cells were grown in 1L LB medium, in the presence of kanamycin, at 37°C, with shaking, to an optical density of 0.5–0.6. The temperature was then reduced to 18°C and protein expression was induced with IPTG to a final concentration of 0.5 mM. Cells were allowed to grow for 16 h. The cultures were then centrifuged at 5,000 rpm and 4°C for 15 min and the resulting pellets were stored at −20°C. For protein purification, pellets were resuspended in buffer A (500 mM NaCl, 20 mM imidazole, 100 mM Tris-HCl pH 7.5) supplemented with protease inhibitor phenylmethylsulfonyl fluoride (PMSF) 1% (v/v). The slurry was sonicated in a Labsonic 2000 (B. Braun) equipment at 50% of potency for 3 cycles of 1.5 min at intervals of 1 min on ice. The lysed cells were then ultra-centrifuged at 100,000 g for 15 min at 4°C. Supernatants were loaded onto a 5 mL HisTrap HP column (GE Healthcare) previously equilibrated with buffer A. Proteins were eluted by an imidazole concentration gradient between buffer A and buffer B (300 mM NaCl, 500 mM imidazole, 100 mM Tris-HCl pH 7.5). ArdC containing fractions were pooled and diluted to a final NaCl concentration of 200 mM. The resulting protein was then loaded onto a 5 mL HiTrap Heparin HP (GE Healthcare) equilibrated with buffer C (100 mM Tris-HCl pH 7.5, 200 mM NaCl). Proteins were eluted by a linear gradient between buffer C and D (100 mM Tris-HCl pH 7.5, 1 M NaCl). ArdC containing fractions were concentrated using Amicon Ultra 30k Centrifugal filters (Millipore, Ireland) and loaded onto a Superdex 75 GL10_30 column (GE Healthcare) previously equilibrated with buffer E (100mM Tris-HCl pH 7.5, 1 mM EDTA, 300 mM NaCl).
To crystallize ArdC with a metal cofactor, cell lysis and the two first purification steps were done as described but with 1 mM MnCl2 in all buffers. Preparation of selenomethionine (SeMet)-labelled ArdC was also carried out as described above but using strain E. coli β834 (DE3) and minimal medium (SelenoMet Medium Base + SelenoMet Nutrient Mix) supplemented with SelenoMethionine Solution (Molecular Dimensions) as indicated by the manufacturer.
Protein crystallization and structure determination
Crystals of ArdC and ArdC-SeMet were obtained using the sitting-drop vapor-diffusion method at 22°C by mixing 1.5 μL protein at 20 mg/mL concentration in 20 mM Tris-HCl, 50 mM NaCl, 1 mM EDTA buffer with an equal volume of the reservoir solution containing 0.1 M HEPES pH 7.5; 10% w/v polyethylene glycol 6,000 and 5% v/v (+/-)-2-methyl-2,4-pentanediol. 2-methyl-2 4-pentanediol (10–20% v/v) was added as cryoprotectant before diffraction experiments. ArdC-Mn crystallized at 12 mg/mL in 25% v/v ethylene glycol and crystals were cryoprotected with additional 15% glycerol.
For data collection, the crystals were flash-frozen in liquid nitrogen at 105 K. For single ArdC-SeMet crystals data was collected at 0.9793Å, the wavelength corresponding to the Selenium absorption maximum according to the fluorescence scan. Datasets were obtained at beamline XALOC at the ALBA Synchrotron Radiation Facility (Barcelona, Spain) with a Dectris PILATUS3 6M Pixel detector. Diffraction images were processed using iMosflm [56] and Scala [57] as part of the CCP4 package [58]. The structure was solved by single anomalous dispersion (SAD) phasing using the program AutoSol of the PHENIX package [59]. The refinement of the initial model was performed through several cycles by Phenix refine [59] until appropriate R factors were reached. Final manual modeling was done in COOT [60]. The ArdC-Mn structure was solved by MR using the ArdC structure as a template.
Electrophoretic mobility shift assay (EMSA)
The binding ability of the ArdC protein to ssDNA, dsDNA, and dsDNA with ssDNA overhangs was tested by electrophoresis mobility shift assay (EMSA). 6FAM-labeled oligonucleotide Fluor-T87I2 (45 bases) was incubated alone or with T87I1 oligonucleotide (45 complementary bases), Mid1 oligonucleotide (13 5’ terminal complementary bases) or Mid2 oligonucleotide (27 3’ terminal complementary bases) (see S9 Table) in buffer containing 50mM Tris-HCl (pH 7.5) and 1mM EDTA for 5 min at 95°C and the mixtures were cooled down slowly to room temperature. 50 nM DNA was incubated with various concentrations of ArdC (0, 125 nM, 250 nM, 500 nM and 1 μM) in a reaction buffer [50 mM NaCl, 25 mM Tris-HCl (pH 7.5), 0.5 mM EDTA] at room temperature for 30 min. DNA-protein complexes were analyzed using non-denaturing polyacrylamide gel electrophoresis 10% (29:1) in cold Tris Borate EDTA (TBE) buffer 1x. Gels were run at 100 V for 75 min and analyzed using a Fujifilm fluorescent image analyzer Fla-5100. Experiments were repeated three times.
Extended Materials and Methods are included in S1 Text.
Supporting information
S1 Text [docx]
Supplementary Materials and Methods.
S1 Fig [tif]
Genetic map of R388 plasmid.
S2 Fig [3]
Retardation and protection of ssDNA (M13mp18) by ArdC from degradation by HhaI.
S3 Fig [tif]
Mass spectrometry analysis for protein identification.
S4 Fig [tif]
Differential expression of genes in experiment vs. to test the influence of ArdC in the three reference sequences.
S5 Fig [tif]
Effect of ArdC on plasmid conjugative transfer from . to . wt and mutants at 30°C.
S6 Fig [tif]
Plasmids encoding TOPRIM and DUF1738 domains.
S1 Table [docx]
T value of ArdC in different solutions.
S2 Table [docx]
Conjugation frequencies from . to . .
S3 Table [docx]
TruSeq Stranded mRNA Illumina sequencing results and coverage for each condition.
S4 Table [docx]
Percentage of reads aligned to the three reference sequences by Bowtie2.
S5 Table [docx]
Distribution of the differentially upregulated or downregulated genes for the three reference sequences and conditions.
S6 Table [docx]
Expression profile of R388 genes.
S7 Table [docx]
Expression profile of upregulated . genome-encoded genes in the absence of in the plasmid.
S8 Table [docx]
Expression profile of differentially upregulated . genes in the presence/absence of .
S9 Table [docx]
Oligonucleotides used in this study.
Zdroje
1. Soucy SM, Huang J, Gogarten JP. Horizontal gene transfer: Building the web of life. Nat Rev Genet. 2015;16: 472–482. doi: 10.1038/nrg3962 26184597
2. Craig MacLean R., San Millan A. The Evolution of Antibiotic Resistance. Science. 2019;365: 1082–1083. doi: 10.1126/science.aax3879 31515374
3. Garcillán-Barcia MP, de la Cruz F. Why is entry exclusion an essential feature of conjugative plasmids? Plasmid. 2008;60: 1–18. doi: 10.1016/j.plasmid.2008.03.002 18440635
4. Frost LS, Koraimann G. Regulation of bacterial conjugation: Balancing opportunity with adversity. Future Microbiol. 2010;5: 1057–1071. doi: 10.2217/fmb.10.70 20632805
5. Petrova V, Chitteni-Pattu S, Drees JC, Inman RB, Cox MM. An SOS Inhibitor that Binds to Free RecA Protein: The PsiB Protein. Mol Cell. 2009;36: 121–130. doi: 10.1016/j.molcel.2009.07.026 19818715
6. Bagdasarian M, Bailone A, Angulo JF, Scholz P, Bagdasarian M, Devoret R. PsiB, and anti-SOS protein, is transiently expressed by the F sex factor during its transmission to an Escherichia coli K-12 recipient. Mol Microbiol. 1992;6: 885–893. doi: 10.1111/j.1365-2958.1992.tb01539.x 1318487
7. Marraffini LA. CRISPR-Cas immunity in prokaryotes. Nature. 2015;526: 55–61. doi: 10.1038/nature15386 26432244
8. Gormley NA, Watson MA, Halford SE. Bacterial Restriction–Modification Systems. Encycl Life Sci. 2005; 1–11. doi: 10.1038/npg.els.0001037
9. Wilkins BM. Plasmid promiscuity: meeting the challenge of DNA immigration control. Environ Microbiol. 2002;4: 495–500. doi: 10.1046/j.1462-2920.2002.00332.x 12220405
10. Tock MR, Dryden DTF. The biology of restriction and anti-restriction. Curr Opin Microbiol. 2005;8: 466–472. doi: 10.1016/j.mib.2005.06.003 15979932
11. Murray NE. Type I restriction systems: Sophisticated molecular machines. Microbiol Mol Biol Rev. 2000;64: 412–434. doi: 10.1128/mmbr.64.2.412-434.2000 10839821
12. Fernández-López R, Pilar Garcillán-Barcia M, Revilla C, Lázaro M, Vielva L, De La Cruz F. Dynamics of the IncW genetic backbone imply general trends in conjugative plasmid evolution. FEMS Microbiol Rev. 2006;30: 942–966. doi: 10.1111/j.1574-6976.2006.00042.x 17026718
13. Chen CY, Kado CI. Inhibition of Agrobacterium tumefaciens oncogenicity by the osa gene of pSa. J Bacteriol. 1994;176: 5697–5703. doi: 10.1128/jb.176.18.5697-5703.1994 8083162
14. Belogurov AA, Delver EP, Agafonova O V, Belogurova NG, Lee LY, Kado CI. Antirestriction protein Ard (Type C) encoded by IncW plasmid pSa has a high similarity to the “protein transport” domain of TraC1 primase of promiscuous plasmid RP4. J Mol Biol. 2000;296: 969–977. doi: 10.1006/jmbi.1999.3493 10686096
15. Krishnan A, Burroughs AM, Iyer LM, Aravind L. Unexpected Evolution of Lesion-Recognition Modules in Eukaryotic NER and Kinetoplast DNA Dynamics Proteins from Bacterial Mobile Elements. iScience. 2018;9: 192–208. doi: 10.1016/j.isci.2018.10.017 30396152
16. Holm L, Sander C. Dali: a network tool for protein structure comparison. Trends Biochem Sci. 1995;20: 478–480. doi: 10.1016/s0968-0004(00)89105-7 8578593
17. Min J-H, Pavletich NP. Recognition of DNA damage by the Rad4 nucleotide excision repair protein. Nature. 2007;449: 570–575. doi: 10.1038/nature06155 17882165
18. Li F, Raczynska JE, Chen Z, Yu H. Structural Insight into DNA-Dependent Activation of Human Metalloprotease Spartan. Cell Rep. 2019;26: 3336–3346. doi: 10.1016/j.celrep.2019.02.082 30893605
19. Wang Y, Xu Q, Lu H, Lin L, Wang L, Xu H, et al. Protease activity of PprI facilitates DNA damage response: Mn(2+)-dependence and substrate sequence-specificity of the proteolytic reaction. Huen MS-Y, editor. PLoS ONE. 2015;10: e01220: 1–17. doi: 10.1371/journal.pone.0122071 25811789
20. Cerdà-Costa N, Gomis-Rüth FX. Architecture and function of metallopeptidase catalytic domains. Protein Soc. 2014;23: 123–144. doi: 10.1002/pro.2400 24596965
21. Fukasawa KM, Hata T, Ono Y, Hirose J. Metal Preferences of Zinc-Binding Motif on Metalloproteases. J Amino Acids. 2011;574816: 1–7. doi: 10.4061/2011/574816 22312463
22. Matthews BW. Structural Basis of the Action of Thermolysin and Related Zinc Peptidases Inhibitor Binding. Acc Chem Res. 1988;21: 333–340.
23. Fernandez-Lopez R, del Campo I, Revilla C, Cuevas A, de la Cruz F. Negative Feedback and Transcriptional Overshooting in a Regulatory Network for Horizontal Gene Transfer. PLoS Genet. 2014;10: e10041: 1–15. doi: 10.1371/journal.pgen.1004171 24586200
24. Merryweather A, Rees CE, Smith NM, Wilkins BM. Role of sog polypeptides specified by plasmid ColIb-P9 and their transfer between conjugating bacteria. EMBO J. 1986;5: 3007–3012. 3024972
25. Serfiotis-Mitsa D, Herbert AP, Roberts GA, Soares DC, White JH, Blakely GW, et al. The structure of the KlcA and ArdB proteins reveals a novel fold and antirestriction activity against Type I DNA restriction systems in vivo but not in vitro. Nucleic Acids Res. 2010;38: 1723–1737. doi: 10.1093/nar/gkp1144 20007596
26. Goryanin II, Kudryavtseva AA, Balabanov VP, Biryukova VS, Manukhov IV, Zavilgelsky GB. Antirestriction activities of KlcA (RP4) and ArdB (R64) proteins. FEMS Microbiol Lett. 2018;365. doi: 10.1093/femsle/fny227 30239714
27. Garcillán-Barcia MP, Redondo-Salvo S, Vielva L, de la Cruz F. MOBscan: Automated Annotation of MOB Relaxases. Methods Mol Biol Clifton NJ. 2020;2075: 295–308. doi: 10.1007/978-1-4939-9877-7_21 31584171
28. Melkina OE, Goryanin II, Zavilgelsky GB. The DNA–mimic antirestriction proteins ArdA ColIB-P9, Arn T4, and Ocr T7 as activators of H-NS-dependent gene transcription. Microbiol Res. 2016;192: 283–291. doi: 10.1016/j.micres.2016.07.008 27664747
29. Serfiotis-Mitsa D, Herbert AP, Roberts GA, Soares DC, White JH, Blakely GW, et al. The structure of the KlcA and ArdB proteins reveals a novel fold and antirestriction activity against type I DNA restriction systems in vivo but not in vitro. Nucleic Acids Res. 2009;38: 1723–1737. doi: 10.1093/nar/gkp1144 20007596
30. Devigne A, Ithurbide S, Bouthier de la Tour C, Passot F, Mathieu M, Sommer S, et al. DdrO is an essential protein that regulates the radiation desiccation response and the apoptotic-like cell death in the radioresistant Deinococcus radiodurans bacterium. Mol Microbiol. 2015;96: 1069–1084. doi: 10.1111/mmi.12991 25754115
31. Baharoglu Z, Bikard D, Mazel D. Conjugative DNA transfer induces the bacterial SOS response and promotes antibiotic resistance development through integron activation. PLoS Genet. 2010;6: e100116: 1–10. doi: 10.1371/journal.pgen.1001165 20975940
32. Roer L, Aarestrup FM, Hasman H. The EcoKI type I restriction-modification system in Escherichia coli affects but is not an absolute barrier for conjugation. J Bacteriol. 2015;197: 337–342. doi: 10.1128/JB.02418-14 25384481
33. Grant SG, Jessee J, Bloom FR, Hanahan D. Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants. Proc Natl Acad Sci. 1990;87: 4645–4649. doi: 10.1073/pnas.87.12.4645 2162051
34. Studier FW, Moffatt BA. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986;189: 113–130. doi: 10.1016/0022-2836(86)90385-2 3537305
35. Miroux B, Walker JE. Over-production of proteins in Escherichia coli: Mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J Mol Biol. 1996;260: 289–298. doi: 10.1006/jmbi.1996.0399 8757792
36. Budisa N, Steipe B, Demange P, Eckerskorn C, Kellermann J, Huber R. High-level biosynthetic substitution of methionine in proteins by its analogs 2-aminohexanoic acid, selenomethionine, telluromethionine and ethionine in Escherichia coli. Eur J Biochem. 1995;230: 788–796. doi: 10.1111/j.1432-1033.1995.tb20622.x 7607253
37. Yu D, Ellis HM, Lee E-C, Jenkins NA, Copeland NG, Court DL. An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci. 2000;97: 5978–5983. doi: 10.1073/pnas.100127597 10811905
38. Silver PA, Stirling F, Bitzan L, Way J, Oliver JWK, Redfield E, et al. Rational Design of Evolutionarily Stable Microbial Kill Switches. Mol Cell. 2017;68:.e3: 686–697. doi: 10.1016/j.molcel.2017.10.033 29149596
39. Lee EC, Yu D, Martinez De Velasco J, Tessarollo L, Swing DA, Court DL, et al. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics. 2001;73: 56–65. doi: 10.1006/geno.2000.6451 11352566
40. Keasling JD, Wanner BL, Skaug T, Datsenko KA, Khlebnikov A. Homogeneous expression of the PBAD promoter in Escherichia coli by constitutive expression of the low-affinity high-capacity AraE transporter. Microbiology. 2001;147: 3241–3247. doi: 10.1099/00221287-147-12-3241 11739756
41. del Campo I, Ruiz R, Cuevas A, Revilla C, Vielva L, de la Cruz F. Determination of conjugation rates on solid surfaces. Plasmid. 2012;67: 174–182. doi: 10.1016/j.plasmid.2012.01.008 22289895
42. Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, et al. The complete genome sequence of Escherichia coli K-12. Science. 1997;277: 1453–1462. doi: 10.1126/science.277.5331.1453 9278503
43. Wang HH, Isaacs FJ, Carr PA, Sun ZZ, Xu G, Forest CR, et al. Programming cells by multiplex genome engineering and accelerated evolution. Nature. 2009;460: 894–898. doi: 10.1038/nature08187 19633652
44. Bagdasarian M, Lurz R, Riickert B, Bagdasarian MM, Frey J, Timmis KN. Specific-purpose plasmid cloning vectors II. Broad host range, high copy number, RSF1010-derived gene cloning in Pseudomon. Gene. 1981;16: 237–247. doi: 10.1016/0378-1119(81)90080-9 6282695
45. Martínez-García E, Nikel PI, Aparicio T, de Lorenzo V. Pseudomonas 2.0: Genetic upgrading of P. putida KT2440 as an enhanced host for heterologous gene expression. Microb Cell Factories. 2014;13: 1–15. doi: 10.1186/s12934-014-0159-3 25384394
46. Rosenberg C, Huguet T. The pAtC58 plasmid of Agrobacterium tumefaciens is not essential for tumour induction. MGG Mol Gen Genet. 1984;196: 533–536. doi: 10.1007/BF00436205
47. Datta Naomi & Hedges R. W. Trimethoprim Resistance Conferred by W Plasmids in Enterobacteriaceae. J Gen Microbiol. 1972;72: 349–355. doi: 10.1099/00221287-72-2-349 4562309
48. Martinez E, de la Cruz F. Transposon Tn21 encodes a RecA-independent site-specific integration system. Mol Gen Genet. 1988;211: 320–325. doi: 10.1007/bf00330610 2832705
49. Zaslaver A, Bren A, Ronen M, Itzkovitz S, Kikoin I, Shavit S, et al. A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat Methods. 2006;3: 623–628. doi: 10.1038/nmeth895 16862137
50. West SEH, Schweizer HP, Dall C, Sample AK, Runyen-Janecky LJ. Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. Gene. 1994;148: 81–86. doi: 10.1016/0378-1119(94)90237-2 7926843
51. Qiu D, Damron FH, Mima T, Schweizer HP, Yu HD. PBAD-based shuttle vectors for functional analysis of toxic and highly regulated genes in Pseudomonas and Burkholderia spp. and other bacteria. Appl Environ Microbiol. 2008;74: 7422–6. doi: 10.1128/AEM.01369-08 18849445
52. Andrews S. FASTQC A Quality Control tool for High Throughput Sequence Data. In: Babraham Institute [Internet]. 2015. Available: http://www.bioinformatics.babraham.ac.uk/projects/fastqc/Help/3AnalysisModules/
53. Ben Langmead, Steven S. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2013;9: 357–359. doi: 10.1038/nmeth.1923.Fast
54. Carver T, Harris SR, Berriman M, Parkhill J, McQuillan JA. Artemis: An integrated platform for visualization and analysis of high-throughput sequence-based experimental data. Bioinformatics. 2012;28: 464–469. doi: 10.1093/bioinformatics/btr703 22199388
55. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4: 44–57. doi: 10.1038/nprot.2008.211 19131956
56. Battye TGG, Kontogiannis L, Johnson O, Powell HR, Leslie AGW. iMOSFLM: A new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr D Biol Crystallogr. 2011;67: 271–281. doi: 10.1107/S0907444910048675 21460445
57. Evans P, IUCr. Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr. 2006;62: 72–82. doi: 10.1107/S0907444905036693 16369096
58. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, et al. Overview of the CCP4 suite and current developments. Acta Crystallographica Section D: Biological Crystallography. 2011. pp. 235–242. doi: 10.1107/S0907444910045749 21460441
59. Afonine P.V.; Grosse-Kunstleve R.W; Adams P.D. The Phenix refinement framework. CCP4 Newsletter on protein Crystallography 42, contribution 8. 2005.
60. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60: 2126–2132. doi: 10.1107/S0907444904019158 15572765
61. Eddy SR. A new generation of homology search tools based on probabilistic inference. Genome Inform Int Conf Genome Inform. 2009;23: 205–211.
Článek vyšel v časopise
PLOS Genetics
2020 Číslo 4
- Může hubnutí souviset s vyšším rizikem nádorových onemocnění?
- Polibek, který mi „vzal nohy“ aneb vzácný výskyt EBV u 70leté ženy – kazuistika
- Zkoušku z bariatrické chirurgie nejlépe složil ChatGPT-4. Za ním zůstaly Bing a Bard
- Raději si zajděte na oční! Jak souvisí citlivost zraku s rozvojem demence?
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
Nejčtenější v tomto čísle
- Analysis of genes within the schizophrenia-linked 22q11.2 deletion identifies interaction of night owl/LZTR1 and NF1 in GABAergic sleep control
- High expression in maize pollen correlates with genetic contributions to pollen fitness as well as with coordinated transcription from neighboring transposable elements
- Molecular genetics of maternally-controlled cell divisions
- Spastin mutations impair coordination between lipid droplet dispersion and reticulum